Fisher Douglas Carl — SEC insider filings
SEC reporting owner CIK 1572355. 11 insider filings on record with FilingPulse; latest filed 2026-10-29.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2020-09-18 to 2026-10-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | President | 2 | — | — | 6 |
| Precipio, Inc. (PRPO) | Director | 6 | — | — | 6 |
| OBALON THERAPEUTICS INC (OBLN) | Director | 1 | — | — | 2 |
| Aspen Neuroscience, Inc. (ASPE) | Director | 1 | — | — | — |
| SERA PROGNOSTICS, INC. (SERA) | Chief Business Officer | 1 | — | — | — |
Insider filings — Fisher Douglas Carl
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-29 | 3 | Aspen Neuroscience, Inc. (ASPE) | Holdings only — no transactions reported | EDGAR |
| 2024-02-16 | 4 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Other (J): 43,300 · Grant/award (A): 50 (derivative) @ $1,000 · Other (J): 5,000 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | Precipio, Inc. (PRPO) | Grant/award (A): 5,174 | EDGAR |
| 2023-09-14 | 4 | Precipio, Inc. (PRPO) | Grant/award (A): 7,954 | EDGAR |
| 2023-01-10 | 4 | Precipio, Inc. (PRPO) | Grant/award (A): 30,000 (derivative) | EDGAR |
| 2022-03-31 | 4 | SERA PROGNOSTICS, INC. (SERA) | Holdings only — no transactions reported | EDGAR |
| 2022-01-13 | 4 | Precipio, Inc. (PRPO) | Grant/award (A): 40,000 (derivative) | EDGAR |
| 2021-10-12 | 4 | PHOENIX BIOTECH ACQUISITION CORP. (PBAX) | Other (J): 10,000 · Other (J): 100,000 (derivative) · Other (J): 5,000 (derivative) | EDGAR |
| 2021-08-05 | 4 | Precipio, Inc. (PRPO) | Grant/award (A): 25,000 (derivative) | EDGAR |
| 2021-01-05 | 4 | Precipio, Inc. (PRPO) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-09-18 | 4 | OBALON THERAPEUTICS INC (OBLN) | Grant/award (A): 27,250 (derivative) @ $0 · Grant/award (A): 27,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1572355 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs